Loading…
Tuesday, May 14 • 2:00pm - 2:45pm
Panel: From Lab to Market: Navigating the Transition from Clinical to Commercial

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Join our expert panel discussion as we unravel the intricacies of launching a company's first drug and seamlessly transitioning from the clinical stage to commercial success. This session will provide invaluable insights into what is needed to succeed during this critical phase, with a focus on the crucial role that communications and PR teams play in the journey.
  • Discuss the key elements of a successful drug launch plan and strategic considerations, including market positioning, target audiences, and the reimbursement landscape
  • Understand the role of effective communication in maintaining transparency and building trust with regulatory bodies and stakeholders
  • Emphasize the significance of patient-centric communication strategies and ways to effectively communicate with patients, caregivers, and advocacy groups, ensuring a patient-focused approach
  • Explore strategies to align internal teams, from R&D to marketing, ensuring everyone is on the same page for a successful commercial launch and express the importance of internal communication and employee engagement during the transition
Moderators
avatar for Charlotte Smith

Charlotte Smith

Senior Vice President, Head of Public Affairs, Travere Therapeutics
Charlotte Smith serves as the senior vice president of public affairs and is a member of the executive team at Travere Therapeutics. She has over twenty years of experience in the healthcare industry as a senior corporate affairs executive focused on internal and external communications... Read More →

Speakers
avatar for Tom Jones

Tom Jones

Managing Partner, FINN Partners
avatar for Jim Baker

Jim Baker

Senior Vice President, Corporate Affairs, Blueprint Medicines
Jim Baker brings more than 15 years of experience as a biopharmaceutical communications leader building entrepreneurial, science-driven companies from discovery to commercialization, across global markets and through collaboration ecosystems. Since joining Blueprint Medicines as Vice... Read More →
avatar for Christina Chan

Christina Chan

Senior Vice President, Corporate Affairs, Regeneron
Christina Chan joined Regeneron in 2021 and serves as senior vice president, corporate affairs, leading a multidisciplinary team responsible for external & internal communication, patient advocacy, corporate responsibility, ESG strategy & reporting, and social impact. Before joining... Read More →
avatar for John Lacey, MS, MBA

John Lacey, MS, MBA

Head of Corporate Affairs, BioLineRx Ltd.
John has over twenty-five years of life sciences communications experience, including in-house, agency and journalism.  He has successfully implemented communications and investor relations programs across multiple industries, including bio/pharmaceutical, consumer, medical device... Read More →

Tuesday May 14, 2024 2:00pm - 2:45pm PDT
Grand Ballroom (A) Balboa Bay Resort | 1221 West Coast Hwy Newport Beach, CA 92663
  • QTAG featuredsessionv2